Get the Stockscreener App
12.29
5.00%
0.59
Autonomix Medical Inc stock is traded at $12.29, with a volume of 52,683.
It is up +5.00% in the last 24 hours and up +3.41% over the past month.
Autonomix Medical Inc is a development-stage medical device development company focused on advancing innovative technologies for sensing and treating disorders relating to the nervous system. Its first-in-class technology platform includes a catheter-based microchip-enabled array that can detect and differentiate neural signals with a high degree of sensitivity as demonstrated in animal studies.
See More
Previous Close:
$11.70
Open:
$11.45
24h Volume:
52,683
Relative Volume:
0.12
Market Cap:
$13.48M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+17.79%
1M Performance:
+3.41%
6M Performance:
-79.99%
1Y Performance:
+0.00%
1-Day Range:
$10.81
$12.40
1-Week Range:
$9.685
$17.15
52-Week Range:
$7.51
$121.80
Autonomix Medical Inc Stock (AMIX) Company Profile
Name
Autonomix Medical Inc
Sector
Industry
Phone
832-277-7816
Address
21 WATERWAY AVENUE, SUITE 300, THE WOODLANDS
Autonomix Medical Inc Stock (AMIX) Latest News
Autonomix reports results from first 15 patients’ data on transvascular energy - MSN
Autonomix Medical Shares Rise After Positive Trial for Pancreatic Cancer Pain Treatment - MarketWatch
Autonomix (AMIX) Gains Investor Confidence After Encouraging Trial Results - Stocks Telegraph
Autonomix Medical, Inc. Reports New Positive Topline Results from First 15 Patients’ 7-Day Data Highlighting Significant Impact on Treatment of Pancreatic Cancer Pain with Maintained Pain Reduction - StreetInsider.com
Autonomix Medical, Inc. Reports New Positive Topline - GlobeNewswire
Autonomix Medical (AMIX) Reports New Positive Topline Results from First 15 Patients’ 7-Day Data Highlighting Significant Impact on Treatment of Pancreatic Cancer Pain with Maintained Pain Reduction - StreetInsider.com
Autonomix Medical, Inc.’s Dr. Robert Schwartz Discusses - GlobeNewswire
Autonomix participates in Virtual Investor ‘What This Means’ segment - TipRanks
AMIS Stock Surges After RF Ablation Trial Unveils Positive Results - Yahoo Finance
Monte Rosa Therapeutics, Evoke Pharma, and Autonomix Medical: The Top 3 Stocks Capturing Retail Attention - Barchart
Autonomix announces preliminary results from trial on ablation technology - TipRanks
Autonomix Shares Soar 85% on Results From Pain-Management Study - MarketWatch
Crude Oil Tumbles Over 5%; Autonomix Medical Shares Spike Higher - Benzinga
Why Is Nao-Cap Neurology Focused Autonomix Medical Stock Trading Higher On Monday? - Benzinga
Autonomix (AMIX) Stock Soars On Positive Pain Management Trial Outcomes - Stocks Telegraph
Autonomix jumps after its treatment reduces pain during trial - XM
Autonomix reports breakthrough in pancreatic cancer pain - Investing.com India
Positive Preliminary Results Demonstrate Autonomix’s - GlobeNewswire
Positive Preliminary Results Demonstrate Autonomix’s Proprietary RF Ablation Technology’s Ability to Reduce Opioid Use in Ongoing Human Clinical Trial - StockTitan
1,518,000 Common Stock of Autonomix Medical, Inc. are subject to a Lock-Up Agreement Ending on 27-OCT-2024. - Marketscreener.com
Autonomix Medical, Inc. to Participate in a Virtual Investor “What This Means” Segment on Wednesday, October 30th - GlobeNewswire
Autonomix Medical to conduct a reverse stock split - MSN
Autonomix Medical announces 1-for-20 reverse stock split By Investing.com - Investing.com Canada
Nerve ablation tech developer Autonomix to effect a reverse stock split - Mass Device
Autonomix Announces Reverse Stock Split - citybiz
Autonomix Medical announces 1-for-20 reverse stock split - Investing.com
Autonomix Medical ratifies new auditor, approves reverse stock split - Investing.com India
Autonomix Medical ratifies new auditor, approves reverse stock split By Investing.com - Investing.com South Africa
Autonomix Medical, Inc. to Participate in the 2024 Healthcare Virtual Summit, Presented by Maxim Group LLC - GlobeNewswire
This Company Is Taking An Innovative, Non-Opioid Approach To Pain Management For Pancreatic Cancer - AccessWire
Autonomix Flat on Unveiling Corner Segment - Baystreet.ca
Autonomix Medical, Inc. (NASDAQ: AMIX) Announces Release of the Next CEO Corner Segment - GlobeNewswire
Potential Price Increase for Vor Biopharma Inc (VOR) After Recent Insider Activity - Knox Daily
VOR’s Stock Market Adventure: -65.78% YTD Growth Amidst Volatility - The InvestChronicle
Investing in Vor Biopharma Inc (VOR) might be an excellent idea, but the stock is currently overvalued/undervalued - US Post News
Market Resilience: Vor Biopharma Inc (VOR) Finishes Weak at 0.83, Down -7.78 - The Dwinnex
Stock hits 5% upper circuit after Motilal Oswal Mutual Fund bought 2.12% stake - Trade Brains
Motilal Oswal MF buys 2% in smallcap stock that is up 1,515% in 16 months - Business Standard
Autonomix Medical faces potential Nasdaq delisting - Investing.com
Autonomix Selected to Present at the 2024 Octane Medical Innovation Forum - GlobeNewswire
Market Resilience: Vor Biopharma Inc (VOR) Finishes Weak at 0.93, Down -2.48 - The Dwinnex
Vor Biopharma Inc (VOR) requires closer examination - US Post News
Moove, Rappi edge closer to IPOs - LatinFinance
Ladenburg Thalmann Initiates Coverage of Autonomix Medical (AMIX) with Buy Recommendation - MSN
Autonomix rises after it reports reduction of pain in pancreatic cancer treatment - MSN
Autonomix reports pain relief in pancreatic cancer trial - Investing.com India
Autonomix reports pain relief in pancreatic cancer trial By Investing.com - Investing.com Canada
Autonomix reports pain reduction in pancreatic cancer patient treatment - TipRanks
Autonomix Medical Inc Stock (AMIX) Financials Data
There is no financial data for Autonomix Medical Inc (AMIX). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.55%
0.53%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):